Evidence map›Paper›PMID 41398995›Full record

ArticleCancer biology & medicine2025

Harnessing the STING pathway for HCC treatment.

Carmen Chak-Lui Wong, Cerise Yuen-Ki Chan, Helen Do-Gai Xue, Chun-Ming Wong

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer biology & medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Carmen Chak-Lui Wong *Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.ORCID 0000-0001-5866-4705
Cerise Yuen-Ki Chan *Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Helen Do-Gai Xue *Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Chun-Ming WongDepartment of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.ORCID 0000-0002-2497-7858

Funding

Health and Medical Research Fund [HMRF] 08192516Health and Medical Research Fund [HMRF] 11221526National Natural Science Foundation of China - Distinguished Young Scholars Fund 82425043Research Grant Council Collaborative Research Fund [RGC CRF] C5016-23GResearch Grant Council Collaborative Research Fund [RGC CRF] C7008-22GResearch Grant Council Research Fellow Scheme [RGC RFS] 2024 RFS2425-7S01Research Grant Council Research Impact Fund [RGC RIF] R5008-22Research Grant Council Theme Based Research Scheme [RGC TBRS] T12-716/22-RShenzhen Science and Technology Program ZDSYS20210623091811035
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41398995
PMCPMC12724292

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.